GO:0046394 carboxylic acid biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046394 (carboxylic acid biosynthetic process) describes the chemical reactions and pathways that build carboxylic acids, any organic acid containing one or more carboxyl (-COOH) groups.
• Carboxylic acid reductases (CARs) are central enzymes that catalyze the ATP- and NADPH-dependent reduction of carboxylic acids to aldehydes, a key step in biosynthesis and metabolic engineering.
• Carboxylic acid transporters and receptors, such as HCA receptors, mediate the uptake, sensing, and metabolic effects of carboxylic acids in pathogens and human tissues.
• Metabolic activation and detoxification of carboxylic acids, including hydroxamic acid hydrolysis, are critical for drug metabolism and toxicity.
• Dysregulation of carboxylic acid biosynthesis is linked to metabolic disorders, microbial pathogenesis, and cancer, making it a target for therapeutic and biotechnological intervention.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of carboxylic acid biosynthetic genes in disease and metabolic engineering.
Description
Carboxylic acids are fundamental metabolites in all living organisms, serving as building blocks for amino acids, fatty acids, and secondary metabolites. The Gene Ontology term GO:0046394, carboxylic acid biosynthetic process, encompasses the enzymatic reactions and pathways that generate these organic acids, which contain one or more carboxyl (-COOH) groups. This process is essential for cellular metabolism, energy production, and the synthesis of numerous bioactive molecules. Understanding the molecular machinery behind carboxylic acid biosynthesis has broad implications for metabolic engineering, drug development, and disease research. Recent advances in enzymology have elucidated the structure and mechanism of carboxylic acid reductases (CARs), which catalyze the reduction of carboxylic acids to aldehydes, a rate-limiting step in many biosynthetic pathways. These enzymes are attractive targets for producing biofuels, pharmaceuticals, and industrial chemicals. Moreover, carboxylic acid transporters and receptors regulate the uptake and signaling of these metabolites, influencing pathogenesis and metabolic homeostasis. This article provides a comprehensive overview of GO:0046394, covering its definition, biological significance, key genes, regulatory mechanisms, disease associations, and cutting-edge research methods including CRISPR-based models.
carboxylic acid biosynthetic process At A Glance
| GO ID | GO:0046394 |
|---|---|
| GO term | carboxylic acid biosynthetic process |
| Ontology | biological_process |
| Synonym | carboxylic acid anabolism, carboxylic acid biosynthesis, carboxylic acid formation, carboxylic acid synthesis |
| Major function | Synthesis of carboxylic acids, including amino acids, fatty acids, and secondary metabolites |
| Key enzymes | Carboxylic acid reductases (CARs), synthases, dehydrogenases, and transporters |
| Related pathways | Metabolic engineering, drug metabolism, microbial pathogenesis |
| Research relevance | Target for biofuels, pharmaceuticals, and disease therapeutics |
What Is GO:0046394?
GO:0046394, carboxylic acid biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of carboxylic acids, which are organic acids containing one or more carboxyl (-COOH) groups. This biological process includes anabolism, biosynthesis, formation, and synthesis of carboxylic acids, and is carried out by a diverse array of enzymes across all domains of life.
Why Is carboxylic acid biosynthetic process Important in Cell Biology?
Carboxylic acid biosynthetic process is vital because carboxylic acids are central to cellular metabolism, serving as precursors for amino acids, lipids, and cofactors, and as signaling molecules. Dysregulation of this process contributes to metabolic disorders, cancer, and infectious diseases, while its manipulation enables the sustainable production of chemicals and fuels.
• Provides essential building blocks for amino acids, fatty acids, and secondary metabolites.
• Enables metabolic engineering of biofuels and industrial chemicals.
• Carboxylic acid reductases are key biocatalysts for aldehyde production.
• Transporters and receptors regulate carboxylic acid uptake and signaling in pathogens.
• Hydroxy-carboxylic acid receptors modulate metabolic and inflammatory responses.
• Metabolic activation of carboxylic acids can lead to drug toxicity.
• Hydroxamic acid metabolism to carboxylic acids impacts drug disposition.
• Dysregulation is linked to cancer, diabetes, and microbial infections.
• CRISPR screens can identify novel genes in carboxylic acid biosynthesis.
• Targeted editing enables production of high-value compounds in cell factories.
What Happens During carboxylic acid biosynthetic process?
Substrate Activation and Carboxylation
In simple terms: The cell first activates simple molecules and adds a carboxyl group to them.
The biosynthesis of carboxylic acids often begins with the activation of a substrate, such as a hydrocarbon or an alpha-keto acid, followed by carboxylation. For example, in fatty acid biosynthesis, acetyl-CoA is carboxylated to malonyl-CoA by acetyl-CoA carboxylase. This step requires ATP and bicarbonate and is a committed step in the pathway. Carboxylic acid reductases (CARs) can also activate carboxylic acids by adenylation, forming an acyl-AMP intermediate, which is then reduced.
Reduction and Aldehyde Formation
In simple terms: Some carboxylic acids are converted into aldehydes, which are reactive building blocks.
Carboxylic acid reductases (CARs) catalyze the ATP- and NADPH-dependent reduction of carboxylic acids to their corresponding aldehydes. This two-step reaction involves the formation of an acyl-AMP intermediate, followed by reduction to the aldehyde via a thioester intermediate. CARs are found in bacteria, fungi, and plants and are involved in the biosynthesis of aldehydes, alcohols, and hydrocarbons. The structure and mechanism of CARs have been elucidated, revealing a modular architecture with an adenylation domain, a reductase domain, and a phosphopantetheine arm.
Transport and Compartmentalization
In simple terms: Carboxylic acids must be moved into and out of cells and organelles.
Carboxylic acid transporters facilitate the uptake and efflux of carboxylic acids across cellular membranes. In Candida species, carboxylic acid transporters are involved in pathogenesis and metabolic adaptation. In humans, hydroxy-carboxylic acid receptors (HCA receptors) sense carboxylic acids and regulate metabolic processes. Compartmentalization of carboxylic acid biosynthesis occurs in mitochondria, peroxisomes, and the cytosol, depending on the pathway.
Metabolic Activation and Detoxification
In simple terms: The body processes carboxylic acids to make them easier to excrete or to activate them for other functions.
Carboxylic acids can undergo metabolic activation to form reactive intermediates, such as acyl glucuronides or CoA thioesters, which can be toxic. Hydroxamic acids, which contain a carboxylic acid group, are metabolized to carboxylic acids via oxidation or hydrolysis, affecting drug disposition. These pathways are critical for detoxification and drug metabolism.
Key Genes Involved in GO:0046394 carboxylic acid biosynthetic process
The following genes and proteins are key players in carboxylic acid biosynthetic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAR (carboxylic acid reductase) | Reduces carboxylic acids to aldehydes | Biocatalysis, metabolic engineering |
| ACACA | Carboxylates acetyl-CoA to malonyl-CoA | Fatty acid biosynthesis, cancer metabolism |
| ACACB | Carboxylates acetyl-CoA in mitochondria | Energy homeostasis, diabetes |
| HCA1 (GPR81) | Receptor for lactate and hydroxy-carboxylic acids | Metabolic regulation, inflammation |
| HCA2 (GPR109A) | Receptor for butyrate and niacin | Lipid metabolism, inflammation |
| HCA3 (GPR109B) | Receptor for beta-hydroxy acids | Metabolic disorders |
| Candida carboxylic acid transporters | Uptake of carboxylic acids | Pathogenesis, antifungal targets |
| ALDH | Oxidizes aldehydes to carboxylic acids | Detoxification, drug metabolism |
| ADH | Reduces aldehydes to alcohols | Fermentation, metabolic engineering |
| FASN | Synthesizes fatty acids from acetyl-CoA and malonyl-CoA | Cancer, obesity |
| ACC | Acetyl-CoA carboxylase | Fatty acid synthesis, metabolic engineering |
| P450 | Oxidizes hydrocarbons to carboxylic acids | Drug metabolism, bioremediation |
| UGT | Glucuronidates carboxylic acids | Drug metabolism, detoxification |
| Acyl-CoA synthetase | Activates carboxylic acids to CoA thioesters | Metabolic activation, toxicity |
| Hydroxamic acid hydrolase | Hydrolyzes hydroxamic acids to carboxylic acids | Drug metabolism |
| GPR81 | Lactate receptor | Metabolic signaling |
| GPR109A | Butyrate receptor | Inflammation, cancer |
| GPR109B | Beta-hydroxy acid receptor | Metabolic regulation |
How Is carboxylic acid biosynthetic process Regulated?
Carboxylic acid biosynthetic process is regulated at multiple levels, including transcriptional control of biosynthetic genes, allosteric regulation of enzymes by metabolites, and post-translational modifications. For example, acetyl-CoA carboxylase is allosterically activated by citrate and inhibited by palmitoyl-CoA. Carboxylic acid reductases are regulated by ATP and NADPH availability. In Candida, carboxylic acid transporters are regulated in response to pH and nutrient availability. Hydroxy-carboxylic acid receptors mediate feedback regulation of metabolic pathways.
carboxylic acid biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HCA1 (GPR81) | Insulin resistance, inflammation | Knockout mouse, overexpression in adipocytes |
| HCA2 (GPR109A) | Dyslipidemia, atherosclerosis | Point mutation knock-in, KO mouse |
| ACACA | Cancer, obesity | CRISPR KO in cancer cell lines |
| Candida carboxylic acid transporters | Candidiasis | CRISPR KO in Candida albicans |
| CAR | Metabolic engineering, drug metabolism | Overexpression in E. coli or yeast |
Metabolic Disorders and Cancer
Dysregulation of carboxylic acid biosynthesis contributes to metabolic disorders such as obesity and diabetes. For instance, hydroxy-carboxylic acid receptors (HCA1, HCA2) modulate lipid and glucose metabolism, and their dysfunction is linked to insulin resistance. In cancer, increased fatty acid synthesis via acetyl-CoA carboxylase and FASN supports tumor growth.
Microbial Pathogenesis
Carboxylic acid transporters in Candida albicans are essential for nutrient acquisition and virulence, making them potential antifungal targets. Similarly, carboxylic acid reductases in pathogens contribute to survival and pathogenesis.
Drug Metabolism and Toxicity
Metabolic activation of carboxylic acids, such as the formation of acyl glucuronides, can lead to drug-induced toxicity. Hydroxamic acid-containing drugs are metabolized to carboxylic acids, affecting their pharmacokinetics.
From carboxylic acid biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate carboxylic acid biosynthesis? | CRISPR knockout in cell line |
| What is the effect of a point mutation in CAR on substrate specificity? | Point mutation knock-in |
| Can overexpression of CAR increase aldehyde production? | Overexpression cell model |
| How does a tagged CAR localize in cells? | Tagged knock-in (e.g., GFP) |
| Which genes are essential for carboxylic acid biosynthesis? | CRISPR library screening |
| What is the metabolic flux through carboxylic acid pathways? | Metabolomics with isotope labeling |
How to Study the carboxylic acid biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify biosynthetic genes |
| CRISPR screening | Gene essentiality | Discover novel pathway genes |
| Proteomics | Protein abundance | Quantify enzymes |
| Metabolomics | Metabolite levels | Measure pathway flux |
| Enzyme assays | Kinetic parameters | Characterize CARs |
| Fluorescence imaging | Localization and dynamics | Track tagged enzymes |
| Isotope labeling | Metabolic flux | Map biosynthetic routes |
Genomic and Transcriptomic Approaches
RNA-seq and CRISPR screens can identify genes involved in carboxylic acid biosynthesis. For example, CRISPR knockout libraries have been used to discover essential genes in metabolic pathways.
Proteomic and Metabolomic Profiling
Mass spectrometry-based proteomics and metabolomics quantify enzymes and metabolites in carboxylic acid pathways, revealing flux and regulation.
Enzymatic Assays
In vitro assays with purified enzymes, such as carboxylic acid reductases, measure kinetic parameters and substrate specificity.
Imaging and Reporter Systems
Fluorescent reporters and imaging can track carboxylic acid production in live cells, using biosensors or tagged enzymes.
How CRISPR Can Be Used to Study GO:0046394 carboxylic acid biosynthetic process
Knockout
CRISPR knockout of carboxylic acid biosynthetic genes, such as ACACA or CAR, can reveal their essentiality and impact on metabolite production. For example, knocking out ACACA in cancer cells reduces fatty acid synthesis and inhibits growth.
Point Mutation
Point mutations in CAR can alter substrate specificity or catalytic activity, enabling structure-function studies. CRISPR-mediated point mutation knock-in allows precise editing of catalytic residues.
Knock-in
Knock-in of tagged versions of biosynthetic enzymes, such as GFP-CAR, enables live-cell imaging and localization studies. This approach can also be used to introduce disease-associated mutations.
Overexpression
Overexpression of carboxylic acid reductases or transporters can enhance production of valuable carboxylic acids or aldehydes in microbial cell factories.
How EDITGENE Supports carboxylic acid biosynthetic process Research
Researchers studying carboxylic acid biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in metabolite production, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for carboxylic acid biosynthetic process research.
Frequently Asked Questions About carboxylic acid biosynthetic process
What is GO:0046394 carboxylic acid biosynthetic process?
GO:0046394 is a Gene Ontology term describing the chemical reactions and pathways that form carboxylic acids, organic acids with one or more carboxyl groups.
What genes are involved in carboxylic acid biosynthetic process?
Key genes include CAR (carboxylic acid reductase), ACACA, ACACB, FASN, and HCA receptors, among others.
How is carboxylic acid biosynthetic process regulated?
It is regulated by transcriptional control, allosteric regulation, and post-translational modifications, involving ATP and NADPH availability.
What diseases are associated with carboxylic acid biosynthetic process?
Dysregulation is linked to metabolic disorders, cancer, and microbial infections.
What methods are used to study carboxylic acid biosynthetic process?
Methods include RNA-seq, CRISPR screens, proteomics, metabolomics, and enzyme assays.
How can CRISPR be used to study carboxylic acid biosynthetic process?
CRISPR knockout, knock-in, point mutation, and overexpression models enable functional dissection of pathway genes.
What is the role of carboxylic acid reductases in biosynthesis?
CARs reduce carboxylic acids to aldehydes, a key step in biosynthesis and metabolic engineering.
How do carboxylic acid transporters contribute to pathogenesis?
In Candida, transporters mediate uptake of carboxylic acids, supporting virulence.
What are hydroxy-carboxylic acid receptors?
HCA receptors (GPR81, GPR109A, GPR109B) sense carboxylic acids and regulate metabolism and inflammation.
How are carboxylic acids metabolized in drug metabolism?
They can be activated to reactive intermediates or hydrolyzed from hydroxamic acids, affecting drug toxicity.
Conclusion
GO:0046394 carboxylic acid biosynthetic process is a fundamental biological process with wide-ranging implications in metabolism, disease, and biotechnology. Understanding its genes, regulation, and mechanisms offers opportunities for therapeutic intervention and metabolic engineering. CRISPR-based models and advanced omics technologies are indispensable for dissecting this pathway. EDITGENE provides comprehensive services to support your research in this field.
References
- 1. Gahloth D et al.. 2020. Carboxylic acid reductase: Structure and mechanism.. J Biotechnol 307:107-113 PMID: 31689469
- 2. Butler N et al.. 2020. Carboxylic acid reductases in metabolic engineering.. J Biotechnol 307:1-14 PMID: 31628973
- 3. Alves R et al.. 2020. Carboxylic Acid Transporters in Candida Pathogenesis.. mBio 11(3) PMID: 32398310
- 4. Offermanns S. 2017. Hydroxy-Carboxylic Acid Receptor Actions in Metabolism.. Trends Endocrinol Metab 28(3):227-236 PMID: 28087125
- 5. Huang X et al.. 2025. Mechanism of hydroxamic acid group metabolism to carboxylic acid: Oxidation versus hydrolysis.. Drug Metab Dispos 53(10):100151 PMID: 40974980
- 6. Skonberg C et al.. 2008. Metabolic activation of carboxylic acids.. Expert Opin Drug Metab Toxicol 4(4):425-38 PMID: 18433345
- 7. Grenier-Davies MC. 2022. Library Synthesis: Building Block Validation.. Methods Mol Biol 2541:13-16 PMID: 36083537
